Retatrutide + cagrilintide
Retatrutide and cagrilintide each have separate human development programmes, but separate trial findings do not establish that combining them is more effective or safe.
Exact-combination evidence
Community-discussed investigational combination; not established
Retatrutide and cagrilintide each have separate human development programmes, but separate trial findings do not establish that combining them is more effective or safe.
Human combination evidence
No combination-specific controlled human outcome trial identified in current search
Combination safety
No validated combination safety framework; overlapping appetite/GI/metabolic effects create uncertainty
Component evidence and direct combination evidence are kept separate. Study doses or regimens, where mentioned, describe the cited research only and are not recommendations for personal use.